Skip to main content

Table 2 Univariate Cox regression model adjusted for possible predictors estimating cancer-specific and overall survival in 244 patients treated with cyto-reductive nephrectomy for metastatic renal cell carcinoma

From: Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy

  Cancer-specific survival Overall survival
HR 95% CI of HR p value HR 95% CI of HR p value
Age 1.004 0.986–1.023 0.679 1.005 0.989–1.023 0.530
BMI (kg/m 2) Reference (< 20) Reference (< 20)
 20–25 0.778 0.456–1.327 0.356 0.783 0.478–1.283 0.332
  ≥ 25 0.373 0.182–0.762 0.007 0.387 0.202–0.743 0.004
Albumin (g/dL) Reference (< 3.5) Reference (< 3.5)
 3.5–4.3 0.610 0.375–0.991 0.046 0.577 0.371–0.899 0.015
  ≥ 4.3 0.515 0.290–0.916 0.024 0.485 0.286–0.822 0.007
Heng’s criteria Reference (Low risk) Reference (Low risk)
 Intermediate risk 1.265 0.729–2.198 0.403 1.188 0.720–1.961 0.499
 High risk 1.842 0.957–3.546 0.067 1.806 0.999–3.266 0.050
 Cholesterol level (cat.) 2.251 1.285–3.941 0.005 2.100 1.272–3.466 0.004
  1. HR hazard ratio, CI confidence interval, BMI body mass index, cat. Categorical variable